ITGBL1 and non-small cell lung carcinoma: Later, since 2015, there have arisen a dozen or so reports concerning the ITGBL1 role in several human diseases, e.g., breast cancer [13], non-small cell lung cancer (NSCLC) [14,15], HBV-related liver pathologies [16,17], pulmonary fibrosis [15], osteoarthritis [18], colorectal [19,20,21], gastric [22], prostate [23] and ovarian cancer [24,25].